awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36612587-95DDF7D6-84BB-4C8A-AFCD-ED22AA012CD6
Q36612587-95DDF7D6-84BB-4C8A-AFCD-ED22AA012CD6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36612587-95DDF7D6-84BB-4C8A-AFCD-ED22AA012CD6
Treatment options for high-risk chronic lymphocytic leukaemia.
P2860
Q36612587-95DDF7D6-84BB-4C8A-AFCD-ED22AA012CD6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36612587-95DDF7D6-84BB-4C8A-AFCD-ED22AA012CD6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
013b60c28415c5b3f71a0a1406caecbe12a3c3bb
P2860
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.